By Dr Anthony Luke Byrne

Book Chapters

Rachow A; Walker NF; Allwood B; Van Der Zalm MM; Byrne A; Meghji J, 2023, 'The challenge of post-tuberculosis lung disease', in , pp. 191 - 209, http://dx.doi.org/10.1183/2312508X.10025122

Alffenaar JWC; Kim HY; Byrne A; Piubello A; Migliori GB, 2021, 'Monitoring Treatment: Clinical and Programmatic Approach for Drug-Susceptible and Drug-Resistant Tuberculosis', in Essential Tuberculosis, pp. 163 - 170, http://dx.doi.org/10.1007/978-3-030-66703-0_18

Journal articles

Phetsouphanh C; Jacka B; Ballouz S; Jackson KJL; Wilson DB; Manandhar B; Klemm V; Tan HX; Wheatley A; Aggarwal A; Akerman A; Milogiannakis V; Starr M; Cunningham P; Turville SG; Kent SJ; Byrne A; Brew BJ; Darley DR; Dore GJ; Kelleher AD; Matthews GV, 2024, 'Improvement of immune dysregulation in individuals with long COVID at 24-months following SARS-CoV-2 infection', Nature Communications, 15, http://dx.doi.org/10.1038/s41467-024-47720-8

Messina NL; Pittet LF; McDonald E; Moore C; Barry S; Bonten M; Byrne A; Campbell J; Croda J; Croda MG; Dalcolmo M; de Almeida e Val FF; de Oliveira RD; dos Santos G; Douglas MW; Gardiner K; Gwee A; Jardim BA; Kollmann T; Lacerda MV; Lucas M; Lynn DJ; Manning L; Marshall H; O'Connell A; Perrett KP; Post JJ; Prat-Aymerich C; Rocha JL; Rodriguez-Baño J; Wadia U; Warris A; Davidson A; Curtis N, 2024, 'BCG vaccination of healthcare workers for protection against COVID-19: 12-month outcomes from an international randomised controlled trial', Journal of Infection, 89, http://dx.doi.org/10.1016/j.jinf.2024.106245

Almeida CPB; Durand RA; LaHood AN; Byrne AL; Mendoza-Ticona A; Ygnacio E; Durand FE; Lecca L; Vásquez Pita RACL; Guerra D; Wong M; Tintaya K; Mitnick CD, 2024, '“I have to breathe”: A Mixed-Methods Pilot Study to Assess the Feasibility, Acceptability, Cost, and Effectiveness of an Intervention for Post-Tuberculosis Lung Disease', Global Journal of Health Science, 16, pp. 48 - 48, http://dx.doi.org/10.5539/gjhs.v16n8p48

Dupnik K; Rivera VR; Dorvil N; Duffus Y; Akbarnejad H; Gao Y; Liu J; Apollon A; Dumont E; Riviere C; Severe P; Lavoile K; Mendicuti MAD; Pierre S; Rouzier V; Walsh KF; Byrne AL; Joseph P; Cremieux PY; Pape JW; Koenig SP, 2024, 'Potential Utility of C-reactive Protein for Tuberculosis Risk Stratification Among Patients With Non-Meningitic Symptoms at HIV Diagnosis in Low- and Middle-income Countries', Open Forum Infectious Diseases, 11, http://dx.doi.org/10.1093/ofid/ofae356

Chaganti J; Poudel G; Cysique LA; Dore GJ; Kelleher A; Matthews G; Darley D; Byrne A; Jakabek D; Zhang X; Lewis M; Jha N; Brew BJ, 2024, 'Blood brain barrier disruption and glutamatergic excitotoxicity in post-acute sequelae of SARS COV-2 infection cognitive impairment: potential biomarkers and a window into pathogenesis', Frontiers in Neurology, 15, http://dx.doi.org/10.3389/fneur.2024.1350848

Lewthwaite H; Byrne A; Brew B; Gibson PG, 2023, 'Treatable traits for long COVID', Respirology, 28, pp. 1005 - 1022, http://dx.doi.org/10.1111/resp.14596

Cysique LA; Jakabek D; Bracken SG; Allen-Davidian Y; Heng B; Chow S; Dehhaghi M; Staats Pires A; Darley DR; Byrne A; Phetsouphanh C; Kelleher A; Dore GJ; Matthews GV; Guillemin GJ; Brew BJ, 2023, 'The kynurenine pathway relates to post-acute COVID-19 objective cognitive impairment and PASC', Annals of Clinical and Translational Neurology, 10, pp. 1338 - 1352, http://dx.doi.org/10.1002/acn3.51825

Pham JP; Boot M; Stefani M; Chapman S; Byrne A; Abdel-Shaheed C; Girgis L, 2023, 'Disseminated Mycobacterium chelonae infection complicating rheumatoid arthritis: A case report and review of the literature', International Journal of Rheumatic Diseases, 26, pp. 1167 - 1171, http://dx.doi.org/10.1111/1756-185X.14605

Dorvil N; Rivera VR; Riviere C; Berman R; Severe P; Bang H; Lavoile K; Devieux JG; Faustin M; Saintyl G; Mendicuti MD; Pierre S; Apollon A; Dumond E; Forestal GPL; Rouzier V; Marcelin A; McNairy ML; Walsh KF; Dupnik K; Reif LK; Byrne AL; Bousleiman S; Orvis E; Joseph P; Cremieux PY; Pape JW; Koenig SP, 2023, 'Same-day testing with initiation of antiretroviral therapy or tuberculosis treatment versus standard care for persons presenting with tuberculosis symptoms at HIV diagnosis: A randomized open-label trial from Haiti', PLoS Medicine, 20, http://dx.doi.org/10.1371/journal.pmed.1004246

Nightingale R; Carlin F; Meghji J; McMullen K; Evans D; van der Zalm MM; Anthony MG; Bittencourt M; Byrne A; du Preez K; Coetzee M; Feris C; Goussard P; Hirasen K; Bouwer J; Hoddinott G; Huaman MA; Inglis-Jassiem G; Ivanova O; Karmadwala F; Schaaf HS; Schoeman I; Seddon JA; Sineke T; Solomons R; Thiart M; van Toorn R; Fujiwara PI; Romanowski K; Marais S; Hesseling AC; Johnston J; Allwood B; Muhwa JC; Mortimer K, 2023, 'Post-TB health and wellbeing', International Journal of Tuberculosis and Lung Disease, 27, pp. 248 - 283, http://dx.doi.org/10.5588/ijtld.22.0514

Byrne A; Allwood B; Schoeman I; Johnston J; Kalyatanda G; Makanda G; Mortimer K; Mitnick C; Nightingale R; Ozoh O; Rachow A; Van Der Zalm M, 2023, '“Post tuberculosis”: the urgent need for inclusion of lung health outcomes in tuberculosis treatment trials', European Respiratory Journal, 62, http://dx.doi.org/10.1183/13993003.00950-2023

Messina NL; Germano S; McElroy R; Rudraraju R; Bonnici R; Pittet LF; Neeland MR; Nicholson S; Subbarao K; Curtis N; Baena AS; Teo JW; de Lima GT; Abreu C; Abruzzo V; Addlem L; Agius S; Barbosa AAR; Alamrousi A; da Silva dos Santos AA; Al-Hindawi Y; Silveira SAD; da Cruz LA; Anderson J; Nelly A; Anthony C; dos Reis Pereira AASDA; de las Revillas Almajano FA; Arnold A; Arrowsmith B; Azzopardi K; Marti CB; Bahaduri T; Bannister S; Barney S; Barrera L; Barriocanal A; Barros D; Barry S; Bartlett A; Batista L; Muranaka S; Baulman T; Bealing M; Beardsley J; Gutierrez ABM; Bell J; Benson S; Rym B; Bennett-Wood V; Bergant N; Barbosa FB; Bijllaardt W; Bimboese P; de Andrade CB; Blake S; Blauwendraat K; Boersma W; Garcia PB; Bonten M; Boon A; Bourke A; Bowes K; Brasil L; Brophy C; Botten R; Buchanan S; Bucholc J; Burns A; Burrell E; Bustos N; Byrne B; Byrne A; Calbo E; Montes JC; Camesella B; Campbell J; Cangas A; Carlin J; Roque MC; Diogo RCP; Carvalho E; Casas I; Castro E; Castro R; Catterick H; Escobar RCD; Chan J; Cheah J; Chern TY; Chengodu T; Ciaverella M; Clark S; Espindola MAC; Cobbledick A; Colaco C; Collopy S; Comella P; Corbett M; Castro GCE; Palasanthiran P; McMullan B, 2022, 'Off-target effects of bacillus Calmette–Guérin vaccination on immune responses to SARS-CoV-2: implications for protection against severe COVID-19', Clinical and Translational Immunology, 11, pp. e1387, http://dx.doi.org/10.1002/cti2.1387

Menzies NA; Quaife M; Allwood BW; Byrne AL; Coussens AK; Harries AD; Marx FM; Meghji J; Pedrazzoli D; Salomon JA; Sweeney S; van Kampen SC; Wallis RS; Houben RMGJ; Cohen T, 2021, 'Lifetime burden of disease due to incident tuberculosis: a global reappraisal including post-tuberculosis sequelae', The Lancet Global Health, 9, pp. e1679 - e1687, http://dx.doi.org/10.1016/S2214-109X(21)00367-3

Alene KA; Wangdi K; Colquhoun S; Chani K; Islam T; Rahevar K; Morishita F; Byrne A; Clark J; Viney K, 2021, 'Tuberculosis related disability: a systematic review and meta-analysis', BMC Medicine, 19, http://dx.doi.org/10.1186/s12916-021-02063-9

Pittet LF; Messina NL; Gardiner K; Orsini F; Abruzzo V; Bannister S; Bonten M; Campbell JL; Croda J; Dalcolmo M; Elia S; Germano S; Goodall C; Gwee A; Jamieson T; Jardim B; Kollmann TR; Lacerda MVG; Lee KJ; Legge D; Lucas M; Lynn DJ; McDonald E; Manning L; Munns CF; Perrett KP; Prat Aymerich C; Richmond P; Shann F; Sudbury E; Villanueva P; Wood NJ; Lieschke K; Subbarao K; Davidson A; Curtis N; Abreu C; Addlem L; Agius S; Barbosa AAR; Alamrousi A; da Silva dos Santos AA; Al-Hindawi Y; Da Silveira SA; da Cruz LA; Anderson J; Anthony C; de Almeida dos Reis Pereira AAS; de las Revillas Almajano FA; Arnold A; Arrowsmith B; Azzopardi K; Marti CB; Bahaduri T; Barney S; Barrera L; Barriocanal A; Barros D; Bartlett A; Muranaka LBS; Baulman T; Bealing M; Beardsley J; Gutierrez ABM; Bell J; Bennett-Wood V; Bergant N; Barbosa FB; Bijllaardt W; Bimboese P; de Andrade CB; Blauwendraat K; Boersma W; Garcia PB; Bonnici R; Boon A; Bourke A; Bowes K; Brasil L; Brophy C; Buchanan S; Bucholc J; Burns A; Burrell E; Bustos N; Byrne B; Byrne A; Calbo E; Montes JC; Camesella B; Campbell J; Cangas A; Carlin J; Roque MC; Diogo RCP; Carvalho E; Casas I; Castro E; Castro R; Catterick H, 2021, 'BCG vaccination to reduce the impact of COVID-19 in healthcare workers: Protocol for a randomised controlled trial (BRACE trial)', BMJ Open, 11, http://dx.doi.org/10.1136/bmjopen-2021-052101

Migliori GB; Marx FM; Ambrosino N; Zampogna E; Schaaf HS; van der Zalm MM; Allwood B; Byrne AL; Mortimer K; Wallis RS; Fox GJ; Leung CC; Chakaya JM; Seaworth B; Rachow A; Marais BJ; Furin J; Akkerman OW; Al Yaquobi F; Amaral AFS; Borisov S; Caminero JA; Carvalho ACC; Chesov D; Codecasa LR; Teixeira RC; Dalcolmo MP; Datta S; Dinh-Xuan AT; Duarte R; Evans CA; García-García JM; Günther G; Hoddinott G; Huddart S; Ivanova O; Laniado-Laborín R; Manga S; Manika K; Mariandyshev A; Mello FCQ; Mpagama SG; Muñoz-Torrico M; Nahid P; Ong CWM; Palmero DJ; Piubello A; Pontali E; Silva DR; Singla R; Spanevello A; Tiberi S; Udwadia ZF; Vitacca M; Centis R; D'Ambrosio L; Sotgiu G; Lange C; Visca D, 2021, 'Clinical standards for the assessment, management and rehabilitation of post-TB lung disease', International Journal of Tuberculosis and Lung Disease, 25, pp. 797 - 813, http://dx.doi.org/10.5588/ijtld.21.0425

Darley DR; Dore GJ; Byrne AL; Plit ML; Brew BJ; Kelleher A; Matthews GV, 2021, 'Limited recovery from post-acute sequelae of sars-cov-2 at 8 months in a prospective cohort', ERJ Open Research, 7, http://dx.doi.org/10.1183/23120541.00384-2021

Allwood BW; Byrne A; Meghji J; Rachow A; Van Der Zalm MM; Schoch OD, 2021, 'Post-Tuberculosis Lung Disease: Clinical Review of an Under-Recognised Global Challenge', Respiration, 100, pp. 751 - 763, http://dx.doi.org/10.1159/000512531

Joseph Y; Yao Z; Dua A; Severe P; Collins SE; Bang H; Antoine Jean-Juste M; Ocheretina O; Apollon A; McNairy ML; Dupnik K; Cremieux E; Byrne A; Pape JW; Koenig SP, 2021, 'Long-term mortality after tuberculosis treatment among persons living with HIV in Haiti', Journal of the International AIDS Society, 24, http://dx.doi.org/10.1002/jia2.25721

Alffenaar JW; Märtson AG; Heysell SK; Cho JG; Patanwala A; Burch G; Kim HY; Sturkenboom MGG; Byrne A; Marriott D; Sandaradura I; Tiberi S; Sintchencko V; Srivastava S; Peloquin CA, 2021, 'Therapeutic Drug Monitoring in Non-Tuberculosis Mycobacteria Infections', Clinical Pharmacokinetics, 60, pp. 711 - 725, http://dx.doi.org/10.1007/s40262-021-01000-6

Darley D; Matthews G; Dore G; Wilhelm K; Plit M; Stone E; Byrne A; Tonga K; Andresen D; Kelleher A; Cysique L; Cunningham P; Brew B, 2021, 'Persistent symptoms up to four months after community and hospital- managed SARS- CoV- 2 infection', Medical Journal of Australia, http://dx.doi.org/10.5694/mja2.50963

Di Michiel J; Gawthorne J; Shivam A; Maruno K; Cohn S; Lemon C; Liu Z; Byrne A, 2021, 'Lung health in the solomon islands: A mixed methods study', International Journal of COPD, 16, pp. 3093 - 3103, http://dx.doi.org/10.2147/COPD.S331734

Darley DR; Dore GJ; Byrne A; Plit M; Brew BJ; Kelleher A; Matthews GV, 2021, 'Limited recovery from post-acute sequelae of SARS-CoV-2 (PASC) at eight months in a prospective cohort', , http://dx.doi.org/10.1101/2021.03.29.21254211

Coates MM; Kintu A; Gupta N; Wroe EB; Adler AJ; Kwan GF; Park PH; Rajbhandari R; Byrne AL; Casey DC; Bukhman G, 2020, 'Burden of non-communicable diseases from infectious causes in 2017: a modelling study', The Lancet Global Health, 8, pp. e1489 - e1498, http://dx.doi.org/10.1016/S2214-109X(20)30358-2

Allwood BW; Van Der Zalm MM; Amaral AFS; Byrne A; Datta S; Egere U; Evans CA; Evans D; Gray DM; Hoddinott G; Ivanova O; Jones R; Makanda G; Marx FM; Meghji J; Mpagama S; Pasipanodya JG; Rachow A; Schoeman I; Shaw J; Stek C; Van Kampen S; Von Delft D; Walker NF; Wallis RS; Mortimer K, 2020, 'Post-tuberculosis lung health: Perspectives from the First International Symposium', International Journal of Tuberculosis and Lung Disease, 24, pp. 820 - 828, http://dx.doi.org/10.5588/ijtld.20.0067

Robertson DJ; Sanders JG; Towler A; Kramer RSS; Spowage J; Byrne A; Burton AM; Jenkins R, 2020, 'Hyper-realistic Face Masks in a Live Passport-Checking Task', Perception, 49, pp. 298 - 309, http://dx.doi.org/10.1177/0301006620904614

Yeong C; Byrne AL; Cho JG; Sintchenko V; Crighton T; Marais BJ, 2020, 'Use of GeneXpert MTB/RIF on a single pooled sputum specimen to exclude pulmonary tuberculosis among hospital inpatients placed in respiratory isolation', International Journal of Infectious Diseases, 92, pp. 175 - 180, http://dx.doi.org/10.1016/j.ijid.2019.12.024

Byrne AL; Bennett MH; Chatterji R; Symons R; Thomas PS, 2020, 'Arterial and venous blood gases in exacerbations of chronic obstructive pulmonary disease', Internal Medicine Journal, 50, pp. 133 - 134, http://dx.doi.org/10.1111/imj.14692

Byrne AL; Marais BJ; Mitnick CD; Garden FL; Lecca L; Contreras C; Yauri Y; Garcia F; Marks GB, 2019, 'Asthma and atopy prevalence are not reduced among former tuberculosis patients compared with controls in Lima, Peru', BMC Pulmonary Medicine, 19, pp. 40, http://dx.doi.org/10.1186/s12890-019-0804-z

Byrne AL; Fox GJ; Marais BJ, 2018, 'Better than a pound of cure: Preventing the development of multidrug-resistant tuberculosis', Future Microbiology, 13, pp. 577 - 588, http://dx.doi.org/10.2217/fmb-2017-0236

Byrne AL; Marais BJ; Mitnick CD; Garden FL; Lecca L; Contreras C; Yauri Y; Garcia F; Marks GB, 2018, 'Feasibility and yield of screening for non-communicable diseases among treated tuberculosis patients in Peru', International Journal of Tuberculosis and Lung Disease, 22, pp. 86 - 92, http://dx.doi.org/10.5588/ijtld.17.0381

Hovey EJ; Field KM; Rosenthal MA; Barnes EH; Cher L; Nowak AK; Wheeler H; Sawkins K; Livingstone A; Phal P; Goh C; Simes J; Hayden A; Barnes E; Espinoza D; Brown C; Winter D; Tomes B; Pike R; Garrett L; Kilsby H; Freilich R; Arzhintar I; Dowling A; Ranieri N; Jennens R; Osmond F; Patterson KW; Phay A; Byrne A; Begbie S; Williams P; Kirby-Lewis S; Abell F; Plowman L; Flynn J; Inglis P; Ives A; Lobb S; Lwin Z; Woodward N; Crosbie G; Singhal N; Smith S; Whelan M, 2017, 'Continuing or ceasing bevacizumab beyond progression in recurrent glioblastoma: An exploratory randomized phase II trial', Neuro-Oncology Practice, 4, pp. 171 - 181, http://dx.doi.org/10.1093/nop/npw025

Byrne AL; Marais BJ; Mitnick CD; Garden FL; Lecca L; Contreras C; Yauri Y; Garcia F; Marks GB, 2017, 'Chronic airflow obstruction after successful treatment of multidrug-resistant tuberculosis', ERJ Open Research, 3, pp. 00026 - 02017, http://dx.doi.org/10.1183/23120541.00026-2017

Ho J; Byrne AL; Linh NN; Jaramillo E; Fox GJ, 2017, 'Decentralized care for multidrug-resistant tuberculosis: A systematic review and meta-analysis', Bulletin of the World Health Organization, 95, pp. 584 - 593, http://dx.doi.org/10.2471/BLT.17.193375

Hayman YA; Sadofsky LR; Williamson JD; Hart SP; Morice AH, 2017, 'The effects of exogenous lipid on THP-1 cells: an in vitro model of airway aspiration?', ERJ Open Res, 3, http://dx.doi.org/10.1183/23120541.00026-2016

Field KM; Simes J; Nowak AK; Cher L; Wheeler H; Hovey EJ; Brown CSB; Barnes EH; Sawkins K; Livingstone A; Freilich R; Phal PM; Fitt G; Rosenthal MA; Arzhintar I; Garrett L; Byrne A; Dowling A; Ranieri N; Jennens R; Osmond F; Patterson WK; Phay A; Abell F; Plowman L; Flynn J; Hovey E; Kilsby H; Kirby-Lewis S; Singhal N; Smith S; Whelan M; Inglis P; Ives A; Lobb S; Begbie S; Williams P; Lwin Z; Woodward N; Crosbie G; Harrup R; Pyszkowski L; Gauden S; Neville A, 2015, 'Randomized phase 2 study of carboplatin and bevacizumab in recurrent glioblastoma', Neuro-Oncology, 17, pp. 1504 - 1513, http://dx.doi.org/10.1093/neuonc/nov104

Byrne AL; Marais BJ; Mitnick CD; Lecca L; Marks GB, 2015, 'Risk factors for and origins of COPD', The Lancet, 385, pp. 1723 - 1724, http://dx.doi.org/10.1016/S0140-6736(15)60884-4

Byrne AL; Marais BJ; Mitnick CD; Lecca L; Marks GB, 2015, 'Tuberculosis and chronic respiratory disease: A systematic review', International Journal of Infectious Diseases, 32, pp. 138 - 146, http://dx.doi.org/10.1016/j.ijid.2014.12.016

Byrne A; Bennett M; Chatterji R; Symons R; Pace N; Thomas P, 2014, 'Comparison of peripheral venous and arterial blood gas analyses Reply', RESPIROLOGY, 19, pp. 769 - 770, http://dx.doi.org/10.1111/resp.12300

Byrne AL; Bennett M; Chatterji R; Symons R; Pace NL; Thomas PS, 2014, 'Peripheral venous and arterial blood gas analysis in adults: Are they comparable? A systematic review and meta-analysis', Respirology, 19, pp. 168 - 175, http://dx.doi.org/10.1111/resp.12225

Byrne A; Bennett M; Chatterji R; Symons R; Pace N; Thomas P, 2014, 'Reply', Respirology, 19, pp. 769 - 770, http://dx.doi.org/10.1111/resp.12300

Byrne AL; Bennett MH; Pace NL; Thomas P, 2013, 'Peripheral venous blood gas analysis versus arterial blood gas analysis for the diagnosis of respiratory failure and metabolic disturbance in adults', Cochrane Database of Systematic Reviews, 2013, http://dx.doi.org/10.1002/14651858.CD010841

Huang S; Byrne A; Dimitri A; Thomas PS, 2013, 'RESPIRATORY PRESENTATIONS OF STRONGYLOIDIASIS IN A LOW PREVALENCE SETTING', RESPIROLOGY, 18, pp. 82 - 82, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000315589700309&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Parker GB; Brotchie H, 2009, 'Reply', ACTA Psychiatrica Scandinavica, 20, pp. 503 - 503

Conference Papers

Cysique LA; Allen-Davidian Y; Darley DR; Byrne A; Wilhelm K; Dore G; Matthews G; Brew BJ, 2021, '032 Cognitive deficits are associated with anosmia but not anxio-depressive symptoms in COVID-19', in BMJ Neurology Open, BMJ, pp. a12 - a12, presented at Oral abstracts, http://dx.doi.org/10.1136/bmjno-2021-anzan.32

Byrne AL; Goldberg H; Mckenzie D, 2012, 'BRONCHOSCOPY WITH BRONCHIAL LAVAGE VERSUS SPUTUM FOR THE DIAGNOSIS OF SMEAR NEGATIVE MYCOBACTERIUM TUBERCULOSIS', in RESPIROLOGY, WILEY-BLACKWELL, pp. 83 - 83, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000301120800316&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Preprints

Almeida C; Durand R; LaHood A; Byrne A; Mendoza-Ticona A; Ygnacio E; Durand F; Lecca L; Pita R; Guerra D; Wong M; Tintaya K; Mitnick C, 2024, “I have to breathe”: A mixed-methods pilot study to assess the feasibility, acceptability, cost, and effectiveness of an intervention for post-tuberculosis lung disease, http://dx.doi.org/10.21203/rs.3.rs-3813549/v1

Dupnik K; Rivera VR; Dorvil N; Akbarnejad H; Gao Y; Liu J; Apollon A; Dumond E; Riviere C; Severe P; Lavoile K; Duran Mendicuti MA; Pierre S; Rouzier V; Walsh KF; Byrne AL; Joseph P; Cremieux P-Y; Pape JW; Koenig SP, 2023, Potential Utility of C-reactive Protein for Tuberculosis Risk Stratification among Patients with Non-Meningitic Symptoms at HIV Diagnosis in Low- and Middle-Income Countries., http://dx.doi.org/10.1101/2023.12.19.23300232

Back to profile page